Abstract Study Objectives The purpose of this study was to determine if asthma with rhinitis and asthma without rhinitis represent distinct forms of disease. Design We performed a prospective cross-sectional study. Participants The study included healthy controls, participants with asthma without rhinitis, and participants with both asthma and rhinitis. Interventions We compared lung function and airway inflammation between the three groups of participants. Results We recruited 32 participants: 12 normals, 8 asthmatics without rhinitis, and 12 with rhinitis. Compared to asthmatics with rhinitis, asthmatics without rhinitis had more severe airflow limitation (FEV 1 /FVC = 60.6% [IQR = 22.8] vs. 74.8% [IQR = 7.8] and fewer induced sputum eosinophils (2.8 [IQR = 5.8] and 9.6 [IQR = 23.8], respectively). Sputum interleukin-6 correlated inversely with lung function measured by postbronchodilator FEV 1 in the study cohort (Spearman correlation coefficient = -0.55, p \ 0.01). Conclusions Asthmatics without rhinitis tend to have lower lung function and less eosinophilic inflammation in the lung. This small study suggests that asthmatics without rhinitis represent a distinct phenotype of asthma in which low lung function is dissociated from eosinophilic cellular inflammation, and it suggests that larger studies addressing this phenotype are warrented.
Introduction
Rhinitis and sinusitis are very common comorbidities in asthma. Data from the European Community Respiratory Health Survey show that rhinitis is reported in 74-81% of asthmatics [1] . Asthma and rhinitis are likely part of the same disease process, with common inflammatory pathways implicated in the pathogenesis of both conditions. This has led to the concept of a common disease affecting a unified airway [2] . However, not all asthmatic patients have rhinitis (or sinusitis). In a retrospective study, we previously reported that asthmatics without rhinitis or sinusitis have lower lung function than asthmatics with rhinitis or sinusitis [3] . Others have also shown that asthmatics without rhinitis tend to have lower lung function but may have increased symptoms, particularly cough [4] . Taken together, this suggests that asthmatics with and without rhinitis may represent distinct phenotypes of asthma.
The purpose of this study was to determine if asthmatic patients with and without rhinitis had distinct features of inflammation in the lower airway, as this would be further evidence that they represent two distinct entities, and that these patients may require different treatment options. This was a prospective cross-sectional study of three groups of participants: normal control participants, asthmatic participants without rhinitis, and asthmatics with rhinitis. We compared symptoms, lung function, and inflammation as assessed by induced sputum, exhaled nitric oxide, and nasal lavage in the three groups of participants.
Materials and Methods

Participants
The study was approved by the local Institutional Review Board and informed consent was obtained from all participants. We enrolled three groups of participants: normal controls, asthmatics without rhinitis, and asthmatics with perennial rhinitis. Participants were recruited from an outpatient pulmonary clinic and local advertising. All participants were 18 years or older. Normal control participants had no history of asthma, no nasal symptoms, and a negative methacholine challenge test. All asthmatic participants had a physician diagnosis of asthma and physiologic evidence of asthma as either a significant response to bronchodilator or a positive methacholine challenge test (PC20 \8 mg/ml to methacholine). All asthmatics had poorly controlled asthma as ascertained by a score of 1.5 or higher on the Juniper Asthma Control Questionnaire [5] . Asthmatic participants without rhinitis denied having any history of nasal symptoms except during upper respiratory tract infections. Asthmatic participants with rhinitis reported chronic nasal symptoms (for more than 12 weeks). We excluded any participants who had used nasal or systemic steroids in the preceding 6 weeks, but included participants on inhaled corticosteroids because the vast majority of poorly controlled asthmatics in our population are on inhaled corticosteroids. Participants with a greater than 20-pack-year smoking history and anyone who had smoked within the preceding 6 months were also excluded. All testing was done over a 2-week period.
Pulmonary Function Tests
Spirometry was performed according to American Thoracic Society (ATS) guidelines. An improvement in FEV 1 and/or FVC of greater than 12% and greater than 200 ml established reversibility. If an asthmatic participant did not have evidence of bronchodilator responsiveness then he/she had a methacholine challenge test; all normal participants underwent methacholine challenge test. Methacholine challenge was performed according to ATS guidelines [6] .
Exhaled Nitric Oxide (NO) Nitric oxide was collected offline according to procedures recommended by the ATS [7] . Participants were asked to inhale orally to total lung capacity and then immediately perform a slow vital capacity maneuver against an expiratory resistance of 12 cmH 2 O (to exclude nasal NO) into a reservoir bag without a breath-hold. The reservoir was immediately sealed and analyzed within 24 h by an NO analyzer (Sievers Instruments, Boulder, CO).
Induced Sputum
Induced sputum was performed after bronchodilation with albuterol. Sputum was collected after the inhalation of increasing concentrations of saline (3, 4 , and 5% saline for 7 min each). Sputum was kept at 4°C and processed within 2 h of collection. Sputum plugs were separated from saliva within 2 h. Dithiotreitol (DTT; Sputolysin; Calbiochem Corporation, San Diego, CA) was freshly prepared in a 1:10 dilution with phosphate-buffered saline (PBS) and added to the plugs in a volume (in ll) equal to four times the weight of the selected plugs (in mg). Samples were incubated on a roller at room temperature for 15 min, then 4 volumes of PBS were added and the samples were filtered through 48-lm nylon gauze. Cytospins were prepared and stained with DiffQuik. Differential cell counts were determined by two observers blinded to the participants' identity. Slides with greater that 20% squamous epithelial cells were not included in the analysis; 500 nonsquamous cells were counted on each slide.
Sputum supernatant was collected after centrifugation at 400 g for 10 min and frozen at -80°C for later analysis. For the simultaneous quantitation of multiple analytes, sputum supernatant was analyzed in duplicate using the Bio-Plex suspension array system (Bio-Rad, Hercules, CA) according to the manufacturer's instructions. Standards were diluted in 0.9% NaCl plus protease inhibitor mixture. Standard curves were calculated and samples were analyzed using the Bio-Plex Manager software (Bio-Rad).
Nasal Procedures
Participants completed standardized questionnaires that assessed their nasal symptoms [8, 9] . For nasal lavage with saline, 5 ml of saline (0.9%) was instilled into each nostril; after 10 s the lavage fluid was expelled and collected for analysis of cytokines. Nasal lavage was frozen at -80°C for later analysis using the Bio-Plex suspension array system as described above.
Statistical Analysis
Our primary interest was in differences in lower-airway inflammation between asthmatics with and those without rhinitis. We estimated we would have 80% power (a = 0.05) to detect a difference in eosinophil levels between asthmatics with and without rhinitis, assuming a mean level of 10% eosinophils (SD = 5) in those with rhinitis [10, 11] and 3% (SD = 5) in those without rhinitis (which has previously been reported as consistent with noneosinophilic asthma) [12] .
Descriptive statistics were used to summarize the baseline demographics for the study population, which was divided into three groups: normals, asthmatics without rhinitis, and asthmatics with rhinitis. Data were compared using one-way analysis of variance for normally distributed values, Kruskal-Wallis rank sum test for non-normally distributed values, and v 2 test for proportions. We determined correlations between non-normally distributed variables using Spearman's rank correlation. All analyses were performed using STATA 8.2 (StataCorp, College Station, TX).
Results
A total of 12 normal controls, 8 asthmatics without rhinitis, and 12 asthmatics with rhinitis were recruited to the study ( Table 1 ). The study population was predominantly female. Questionnaires pertaining to nasal symptoms confirmed the reliability of the categorization of our groups, as asthmatics without rhinitis and normal controls had minimal nasal symptoms as measured by validated rhinitis and sinusitis questionnaires. Demographics variables were similar between the groups. Participants were predominantly Caucasian.
The asthmatic participants were selected to have symptomatic asthma, as we reasoned that symptomatic asthmatics would have active airway inflammation. Both the asthmatics with and those without rhinitis reported similar symptoms of poorly controlled asthma with a mean Juniper Asthma Control score of greater than 2 in both groups (Table 2) . Although severity of symptoms was similar in both groups, asthmatics without rhinitis tended to have lower lung function as measured by both pre-and postbronchodilator FEV 1 , and they had significantly worse airflow limitation as measured by the absolute ratio of FEV 1 /FVC (Table 2) .
Asthmatics without rhinitis had fewer eosinophils in their induced sputum compared with asthmatics with rhinitis, though more than normal control participants (Fig. 1) . This trend persisted when we excluded participants not on inhaled corticosteroids (median sputum eosinophils in asthmatics without rhinitis not on inhaled corticosteroids was 2.1 [IQR = 4.2]; those with rhinitis 7.7 [IQR = 16.0], p = 0.06). Mean exhaled NO levels measured by the offline method were slightly lower in the asthmatic participants without rhinitis (Fig. 1) , and there was a significant correlation between sputum eosinophilia and exhaled NO in asthmatic participants (Spearman rank correlation coefficient = 0.52, p \ 0.05).
Levels of IL-4, IL-5, and TNFa in induced sputum supernatant were below the detection limit of our assay (1.8 pg/ml). Overall, we did not find significant differences in the differences in sputum cytokines between the three groups (Table 3) , though sputum IL-6 was inversely associated with lower levels of postbronchodilator FEV 1 (Fig. 2) (Spearman correlation coefficient = -0.55, p \ 0.01) in the study cohort as a whole. [8] f Rhinitis Quality of Life Questionnaire scale: 0-6; higher score indicative of more severe impairment. Value shown for nose domain of RQLQ [9] Lung
Nasal lavage cytokines showed no difference in Th2 (IL-4 and IL-5) or Th1 cytokines (TNFa and interferon-c) between the two groups of participants with asthma. There were, however, significantly lower levels of IL-8 in asthmatic participants with rhinitis compared to participants without rhinitis (Table 4) .
Discussion
This study supports the concept that asthmatics without rhinitis represent a separate phenotype of asthma with distinct features in terms of symptoms, spirometric lung function, and cellular inflammatory markers in induced sputum. This prospective trial supports our previous retrospective observation that asthmatics without rhinitis tend to have lower lung function than asthmatics with rhinitis, and it suggests that further investigation into the causes of loss of lung function in these patients is warranted.
Many studies have been published that support the concept that rhinitis in patients with asthma likely represents part of a disease continuum with manifestations at different anatomic sites [2] . In asthmatics with rhinitis, the inflammation in the upper and lower airways is closely linked. Bonay [13] recently showed that nasal allergen challenge in patients with allergic rhinitis led to eosinophilia in induced sputum. Conversely, segmental allergen challenge through a bronchoscope leads to increased interleukin-5 and eosinophils in the nose [14] . Allergen challenge can lead to a systemic response: inhalational challenge leads to the mobilization of cells from the bone marrow [15] , so rhinitis and asthma are likely part of the same disease affecting the entire respiratory system. These elegant studies support the concept of a link between the upper and lower airways, but few studies have focused on asthmatic patients without rhinitis, which likely represents approximately 20% of the asthmatic population [2, 3] .
In a retrospective study of participants in a large clinical trial, we reported that asthmatics without rhinitis had lower lung function compared to asthmatics with rhinitis [3] , supporting the observations of other investigators [4] . The purpose of our current study was to determine if there were pathophysiologic differences in these two groups of asthmatics.
We found distinct features of cellular inflammation in the lower airway of these two groups of asthmatics, who had similar symptoms and a similar prevalence of allergy (by history). Asthmatics without rhinitis had lower levels of eosinophils with similar levels of neutrophils and increased levels of macrophages compared to those with rhinitis. Our results differ from those reported by Gaga et al. [16] , who compared eosinophils in bronchial mucosa of asthmatics with and without rhinitis and reported finding no difference in those with and without rhinitis. However, because they reported levels of bronchial eosinophils in only nine participants, the study may have been too underpowered to detect a difference between the two groups of asthmatics. However, others have also reported a direct correlation between induced sputum eosinophils and sinonasal disease: sinus CT scores correlate with induced sputum eosinophils in patients with chronic rhinosinusitis (and this does not appear to be related to atopic status) [17, 18] . Asthma without rhinitis appears to be characterized by fewer eosinophils. Other investigators have described subgroups of asthmatics with low levels of eosinophils in induced sputum [19, 20] , and they appear less likely to respond to inhaled corticosteroid therapy [21, 22] . One can infer from these previous studies that asthmatics without rhinitis may be less likely to respond to inhaled corticosteroid therapy, though this would require further investigation.
We did find a significant relationship between sputum eosinophils and exhaled NO levels, as has been reported in previous studies [23] . We did not find any correlation between lung function and cellular composition of induced sputum, though our small study was likely underpowered to detect this. However, the trend that we detected-low lung function in patients with fewer eosinophils and neutrophils in induced sputum-contrasts to some recent reports that have found that induced sputum eosinophilia and/neutrophilia correlate with low lung function [24, 25] . Our study population differs from those in these other studies, which did not divide patients according to the presence/absence of rhinitis. The majority of asthma patients in these previous studies likely were similar to our group of asthmatic patients with rhinitis, who are approximately 80% of the asthmatic population. Although we did not find any differences in sputum cytokine expression between the two groups of asthmatics that would explain their different lung function, we speculate that IL-6 may be involved in the pathogenesis of low lung function in both groups of asthmatics, because when considering the entire cohort, IL-6 was inversely associated with postbronchodilator FEV 1 . IL-6 may have effects on the remodeling of the airways. IL-6 is a smooth muscle mitogen [17] and overexpression of IL-6 in the murine airway causes subepithelial fibrosis with collagen deposition [26] . Sputum IL-6 levels have been associated with severity of disease and accelerated decline in FEV 1 in COPD patients [27, 28] , suggesting that asthmatics without rhinitis may share some features of patients with COPD. It is important to note that no patient in this study had a greater than 10-pack-year smoking history, though we did not obtain a history regarding second-hand smoke exposure, which would be of interest in future studies given our current findings.
In nasal lavage, we did not find significant differences between any of the groups in terms of either Th1 cytokines (tumor necrosis factor-a and interferon-c) or Th2 cytokines (interleukins -4 and -5). We did find lower levels of IL-8 in the nasal lavage of asthmatics with perennial rhinitis. This may be related to the chronic nasal disease: although acute nasal allergen challenge increases IL-8 in nasal lavage fluid [29] chronically, IL-8 levels decrease in the nasal lavage fluid of patients with seasonal allergic rhinitis [30] . These observations suggest that there are differences in nasal inflammation in asthmatics with rhinitis and those without rhinitis.
One of the major limitations of our study is that it is a small study with limited power for our secondary endpoints. We were limited in our ability to recruit asthmatics without rhinitis; we were able to recruit only eight participants over a 3-year period (on careful questioning, we found almost all asthmatics will report some history of allergic or perennial nasal symptoms). Our observations will need to be confirmed in a larger study population, which may require a multicenter approach. We did not perform allergy testing in this study, which would have been an interesting covariate and should be included in future studies. However, previous studies suggest that lower-airway eosinophilia in adults is not dependent on atopic status [31] [32] [33] , and one recent publication showed that bronchial eosinophilia was higher in nonatopic asthmatics with nasal polyposis [34] , suggesting that induced sputum eosinophils in asthmatics with sinonasal disease is not related to atopic status.
In conclusion, our data suggest that asthmatics without rhinitis appear to have distinct features compared to asthmatics with rhinitis. Our observations should be confirmed in larger population-based studies. Asthmatics with rhinitis tend to have more severe airflow limitation and fewer eosinophils in their induced sputum. This suggests that they may be less responsive to intervention with inhaled corticosteroids and that loss of lung function in these patients may not be related to eosinophilic inflammation but may be related to altered cytokine expression in the airway. This suggests that future studies are required to confirm these phenotypes of asthma and to investigate if those without rhinitis respond differently to medical treatments. 
